Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
10/2000
10/04/2000EP1040103A1 Anilide derivative, production and use thereof
09/2000
09/27/2000EP1037891A1 Method for preparing mequitazine and novel synthesis intermediate
09/27/2000EP1037886A1 Triazine angiogenesis inhibitors
09/27/2000CN1268133A 2-Aminopyridines containing fused ring substituents as NOS inhibitors
09/27/2000CN1056846C Spiro-azabicyclic compounds useful in therapy
09/26/2000US6124460 Isoquinuclidine derivatives, method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/19/2000US6121459 Reacting aryl-substituted-propargylhydroxylamine with azabicycloketone; oximination
09/19/2000US6121447 Starting with 2-cyanopyrimidine, which is prepared by reacting 2-chloropyrimidine with an alkali cyanide in the presence of 1-azabicyclo(2,2,2)octane or 1,4-diazabicyclo(2,2,2)octane
09/19/2000US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
09/14/2000WO2000053544A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
09/14/2000WO2000053181A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2367126A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/13/2000CN1056373C Process for preparation of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
09/12/2000US6118010 Catalytic reduction of the 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivative
09/12/2000US6117883 Useful for modulating a muscarinic receptor.
09/06/2000EP0665844B1 Substituted benzylaminoquinuclidines as substance p antagonists
08/2000
08/24/2000WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
08/23/2000EP1029853A1 Heteroaromatic bicyclic derivatives useful as anticancer agents
08/23/2000EP1028961A1 Pleuromutilin derivatives as antimicrobials
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/16/2000EP1027046A1 Antagonists of gonadotropin releasing hormone
08/16/2000EP0755374B1 Process for peptide segment condensation
08/15/2000US6103905 Quinoline-indole antimicrobial agents, uses and compositions related thereto
08/15/2000US6103754 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
08/09/2000EP1025109A1 Benzoxazine derivatives, preparation and application in therapy
08/09/2000EP1025099A1 Bis-quaternary ammonium derivatives as neuromuscular relaxants
08/08/2000US6100269 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
08/08/2000CA2188227C Combination antiemetic therapy using nk-1 receptor antagonists
08/03/2000WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
08/01/2000CA2066640C Heterocyclic compounds
07/2000
07/27/2000WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses
07/27/2000CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/26/2000EP1021446A1 Single pot process for producing (z)-azabicyclo oxime ethers
07/26/2000CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases
07/26/2000CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases
07/20/2000WO1999064048A9 Inhibitors of hiv reverse transcriptase
07/19/2000EP1020427A1 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
07/19/2000EP1019051A1 Peripherally acting anti-pruritic opiates
07/19/2000CN1260795A Quaternary ammonium compounds as tachykinin antagenists
07/12/2000EP1018512A1 Novel basic derivatives of benz(e)isoindol-1-ones and pyrrolo(3,4-c)quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use
07/12/2000EP1017395A1 Method for treating premenstrual or late luteal phase syndrome
07/12/2000EP0628041B1 Heterocyclic compounds and their preparation and use
07/12/2000CN1259869A Pharmaceutical compositions contg. cinchonine dichlorhydrate
07/05/2000EP0626961B1 Process for the preparation of cyano-methoxyiminomethyl derivatives
07/04/2000US6083957 Heterocyclic compounds and their preparation and use
06/2000
06/28/2000EP1012131A1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
06/21/2000EP1009403A1 Method for treating schizophrenia
06/21/2000CN1257506A Spiro-quinuclidine derivatives, their preparation and use
06/15/2000WO2000034276A1 Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
06/15/2000WO2000034265A2 Quinoline-indole antimicrobial agents
06/15/2000DE19958246A1 Isochinuclidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende therapeutische Mittel gegen Hypercholesterinämie Isochinuclidinderivate, processes for their preparation containing these compounds and therapeutic agents for hypercholesterolemia
06/15/2000CA2317025A1 Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
06/14/2000EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors
06/14/2000EP1007041A1 Composition for treating pain
06/13/2000US6075145 Reducing quinuclidine-3-one or corresponding salt with a secondary alcohol as hydrogen donar in presnece of amorphous partially dehydrated zirconium hydroxide
06/07/2000EP1005356A1 Novel antibacterial agents
06/06/2000US6071900 Heterocyclic compounds and their use
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352261A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
05/2000
05/31/2000EP1004586A2 Method for producing 2-methylspiro(1,3-Oxathiolane-5,3')quinuclidine
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/24/2000EP1001946A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES
05/24/2000EP1001945A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES
05/18/2000WO2000027790A1 Mutilin compounds
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/16/2000CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists
05/11/2000WO2000026195A1 Novel amino acid heterocyclic amide derivatives useful as nitric oxide synthase inhibitors
05/11/2000WO2000026186A1 Pyrrolidine compounds and medicinal utilization thereof
05/11/2000CA2348879A1 Pyrrolidine compound and pharmaceutical use thereof
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
04/2000
04/26/2000EP0994876A1 Quaternary ammonium compounds as tachykinin antagonists
04/26/2000EP0994875A1 3-pyridyl-1-aza-bicyclo-alkane derivatives for prevention and treatment of cns disorders
04/26/2000EP0777671B1 Spiro-azabicyclic compounds useful in therapy
04/26/2000CN1051767C Benzoxazinones as inhibitors of HIV reverse transcriptase
04/25/2000US6054464 Azabicyclic esters of carbamic acids useful in therapy
04/20/2000WO2000021530A1 Peripherally acting anti-pruritic opiates
04/20/2000CA2346464A1 Peripherally acting anti-pruritic opiates
04/19/2000CN1250652A Compositions contg. benzoxazinone and nucleoside like materials
04/18/2000US6051581 Spiro-azabicyclic compounds useful in therapy
04/18/2000US6051575 Piperazino derivatives as neurokinin antagonists
04/12/2000EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES
04/12/2000EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto
04/05/2000EP0989857A1 Novel therapeutic agents that modulate enzymatic processes
04/04/2000US6046213 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives
04/04/2000CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
04/04/2000CA1340943C Azacyclic compounds and their preparation and use
03/2000
03/29/2000EP0988263A1 Process for the production of radioiodinated neuroreceptor agents
03/28/2000CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
03/22/2000EP0986390A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
03/21/2000US6040442 Process for preparing 1,2,5-thiadiazole containing ethers
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/15/2000EP0984970A1 Spiro-quinuclidine derivatives, their preparation and use
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 58